New ophthalmology company hits the market
"Ascendis Pharma partners with Frazier Life Sciences, RA Capital Management, venBio, and HealthQuest Capital to launch ophthalmology company Eyconis. Eyconis wi
Source: beckersasc.com
Ascendi Transcon News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ascendi Transcon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ascendi Transcon Today - Breaking & Trending Today
Ascendis Stock Plunges As FDA Identifies Deficiencies In Company's New Drug Application
Announced Monday the U.S. Food and Drug Administration identified deficiencies in the company's application for a gland treatment. Meanwhile, ASND stock…
Source: biztoc.com
Ascendis Stock Plunges As FDA Identifies Deficiencies In Company's New Drug Application
Announced Monday the U.S. Food and Drug Administration identified deficiencies in the company's application for a gland treatment. Meanwhile, ASND stock…
Source: biztoc.com
Ascendis crosses FDA finish line with once-weekly growth hormone—but Pfizer is hot on its trail
The FDA gave a thumbs up to Ascendis Pharma’s long-acting growth hormone lonapegsomatropin-tcgd on Wednesday. Now christened Skytrofa, the drug is the first once-weekly therapy for pediatric growth hormone disorder, but a rival from Pfizer is nearing the finish line.
Source: fiercepharma.com